CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...

AdvisorNet Financial Inc lessened its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 14.1% during the fourth ...

SeaCrest Wealth Management LLC trimmed its holdings in CVS Health Co. (NYSE:CVS – Free Report) by 38.2% in the fourth quarter ...

Walgreens has been accused of filing millions of 'dangerous' opioid prescriptions in a lawsuit filed by the Department of ...

A bill filed Thursday (Jan. 16) in the Arkansas Legislature would prohibit pharmacy benefit managers and insurance companies ...

In the report, the FTC said pharmacy benefit managers (PBMs), charge significant markups for cancer, HIV, and other critical ...

CVS Health Corp (CVS) stock saw a decline, ending the day at $51.96 which represents a decrease of $-0.18 or -0.35% from the prior close of $52.14. The stock opened at $51.43 and touched a low of $50.

Reports from Toxic-Free Future and Clean Production Action analyzed how companies are addressing PFAS, PVC and other chemicals of concern in plastics, packaging and more.

CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

During an earnings call on Friday, Walgreens CEO Tim Wentworth made a startling admission about the effects of locking up ...

After more than a decade of defending Trump, Pam Bondi is now the president-elect's nominee to be the country's top ...